These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2513619)

  • 21. Immunotoxins against cancer.
    Brinkmann U; Pastan I
    Biochim Biophys Acta; 1994 May; 1198(1):27-45. PubMed ID: 8199194
    [No Abstract]   [Full Text] [Related]  

  • 22. Appendix. Primary amino acid sequences of toxins.
    Sehnke P; Tonevitsky A
    Targeted Diagn Ther; 1992; 7():479-84. PubMed ID: 1633308
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunotoxins: prospects and problems.
    Mendelsohn J
    J Clin Oncol; 1991 Dec; 9(12):2088-90. PubMed ID: 1960548
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical trials with Pseudomonas exotoxin immunotoxins.
    Pai LH; Pastan I
    Curr Top Microbiol Immunol; 1998; 234():83-96. PubMed ID: 9670614
    [No Abstract]   [Full Text] [Related]  

  • 25. A magic bullet for cancer--how near and how far?
    Schnipper LE; Strom TB
    N Engl J Med; 2001 Jul; 345(4):283-4. PubMed ID: 11474668
    [No Abstract]   [Full Text] [Related]  

  • 26. [Protein engineering of Pseudomonas exotoxin and its targeting therapy of cancer].
    Kondo T
    Tanpakushitsu Kakusan Koso; 1989 Oct; 34(13):1793-803. PubMed ID: 2513619
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent development and optimization of pseudomonas aeruginosa exotoxin immunotoxins in cancer therapeutic applications.
    Wu T; Zhu J
    Int Immunopharmacol; 2021 Jul; 96():107759. PubMed ID: 34162138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology].
    Chiron MF
    Bull Cancer; 1997 Dec; 84(12):1135-40. PubMed ID: 9587366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General strategies in in vivo animal modeling.
    Vallera DA; Blazar BR
    Targeted Diagn Ther; 1992; 7():63-77. PubMed ID: 1633310
    [No Abstract]   [Full Text] [Related]  

  • 30.
    Leshem Y; Pastan I
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30621280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights on
    Morgan RN; Saleh SE; Farrag HA; Aboshanab KM
    Ther Deliv; 2023 Jan; 14(1):31-60. PubMed ID: 36950853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
    Brinkmann U
    In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.